[1]
Dvoryadkin А.А., Polyakov, D.A., Belyakova, E.V., Protsenko, D.N. and Krichevskiy L.А. 2024. Prevention of systemic inflammatory response syndrome after emergency on-pump coronary artery bypass grafting with high-dose ascorbic acid: a prospective randomized controlled trial. Annals of Critical Care. 2 (Apr. 2024), 130–136. DOI:https://doi.org/10.21320/1818-474X-2024-2-130-136.